Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Once again, plenty of protein is a must to avoid muscle loss
Expert Review of Clinical Pharmacology
Each pathway contributes a separate pharmacological signal: GLP-1 receptor agonism slows gastric emptying and reduces appetite signalling in the hypothalamus GIP receptor agonism enhances glucose-dependent insulin secretion and is associated in the literature with effects on lipid handling Glucagon receptor agonism increases energy expenditure and hepatic glucose output, the opposite direction to a glucagon antagonist, and is absent from every dual agonist currently on the UK market How retatrutide compares to dual agonists Tirzepatide (Mounjaro) is a GIP + GLP-1 dual agonist authorised by the MHRA for type 2 diabetes in 2023
The in-person appointment includes a basic health screening, consultation and evaluation with one of our medical providers
US$ 23.39
US$ 27.25
US$ 27.12
US$ 20.49
US$ 22.21
US$ 22.90
US$ 26.37
US$ 28.27
US$ 28.34
US$ 28.47
US$ 22.23
